BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6258174)

  • 1. Effect of captopril on the blood pressure response to angiotensin I in turkeys.
    Fregly MJ; Simpson CF; Palmore WP
    Proc Soc Exp Biol Med; 1981 Jan; 166(1):35-8. PubMed ID: 6258174
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of central angiotensin I conversion by oral captopril.
    Marson O; Ribeiro AB; Tufik S; Kohlmann O; Ramos OL
    Braz J Med Biol Res; 1981 Apr; 14(1):73-6. PubMed ID: 6272920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
    Baum T; Becker FT; Sybertz EJ
    Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of extrarenal and intrarenal converting enzyme inhibition in renal vasodilator response to intravenous captopril.
    Wong PC; Zimmerman BG
    Life Sci; 1980 Oct; 27(14):1291-7. PubMed ID: 6255273
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of captopril on blood pressure and angiotensins I, II and III in sodium-depleted dogs: problems associated with the measurement of angiotensin II after inhibition of converting enzyme.
    Morton JJ; Tree M; Casals-Stenzel J
    Clin Sci (Lond); 1980 Jun; 58(6):445-50. PubMed ID: 6253115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421.
    Cohen ML; Kurz KD
    J Pharmacol Exp Ther; 1982 Jan; 220(1):63-9. PubMed ID: 6273529
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison in normal volunteers of three converting enzyme inhibitors: RHC 3659, MK 421 and captopril.
    Burnier M; Biollaz J; Brunner HR; Turini GA; Gavras H
    Am J Cardiol; 1982 Apr; 49(6):1550-1. PubMed ID: 6280484
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of converting enzyme inhibition with captopril on in vitro angiotensin production in sheep.
    Fei DT; Coghlan JP; Scoggins BA
    Clin Exp Pharmacol Physiol; 1981; 8(5):447-50. PubMed ID: 6276058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between inhibition of pressor response to angiotensin I and blood concentration of captopril following a single oral administration to dogs.
    Koike H; Ikeda T; Komai T; Kawai K; Miyamota M; Shindo H
    Eur J Pharmacol; 1981 Feb; 69(4):447-51. PubMed ID: 6265226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
    Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH
    Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350
    [No Abstract]   [Full Text] [Related]  

  • 11. Blockade of the pressor response to angiotensins I and II in the bullfrog, Rana catesbeiana.
    Harper RA; Stephens GA
    Gen Comp Endocrinol; 1985 Nov; 60(2):227-35. PubMed ID: 3905501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting enzyme inhibition and modulation of plasma renin activity with captopril in anesthetized rats.
    Suzuki M; Satoh S
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):121-36. PubMed ID: 6275810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme blockade by Captopril changes angiotensin II receptors and angiotensinogen concentrations in the brain of SHR-sp and WKY rats.
    Felix D; Schelling P
    Neurosci Lett; 1982 Dec; 34(1):45-50. PubMed ID: 6298670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the protective effect of angiotensin-converting enzyme inhibition in hemorrhagic shock.
    Trachte GJ; Lefer AM
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):54-7. PubMed ID: 228313
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the mechanism of captopril induced hypotension in rats.
    Clarke DE; Wagner LB; Wagner LA
    Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):13-30. PubMed ID: 7020011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatment.
    Mullane KM; Moncada S
    Eur J Pharmacol; 1980 Sep; 66(4):355-65. PubMed ID: 6998710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic captopril infusion in two-kidney, one clip rats with normal plasma renin concentration.
    Wallace EC; Morton JJ
    J Hypertens; 1984 Jun; 2(3):285-9. PubMed ID: 6099389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin I converting enzyme inhibitor (SQ 14225) on control of aldosterone.
    Eguchi T; Saito I; Nakamura R; Yasui T; Saruta T
    Acta Endocrinol (Copenh); 1980 Jun; 94(2):213-20. PubMed ID: 6251687
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal by acetylsalicylic acid of the captopril-induced inhibition of angiotensin converting enzyme in the hindquarters of guinea-pig.
    Melli M; Türker RK
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):87-93. PubMed ID: 6287951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.